Anticatabolic Effect of Branched‐Chain Amino Acid‐Enriched Solutions in Patients with Liver Cirrhosis

An amino acid mixture rich in branched‐chain amino acids and poor in aromatic amino acids was infused in six cirrhotics with altered plasma amino acid profile and normal mental state. The effect on muscle protein catabolism, as measured by urinary excretion of 3‐methylhistidine, was assessed during two consecutive 3‐day periods in which patients received the amino acid mixture alone or in a hypertonic dextrose solution. During a 3‐day basal period, cirrhotics showed increased rates of 3‐methylhistidine excretion as compared to six matched healthy subjects. Both treatments reduced urinary 3‐methylhistidine to normal. During treatment, branched‐chain amino acids failed to normalize, plasma aromatic amino acid concentrations and ammonia declined, and alanine increased. Branched‐chain amino acids are mainly oxidized in skeletal muscle with production of alanine. Reduced muscle protein catabolism following amino acid infusion is consistent with the physiological role of branched‐chain amino acids in suppressing protein breakdown and stimulating protein synthesis. Long‐term therapy with branched‐chain amino acid‐enriched mixtures may prove useful in advanced cirrhotics with severe muscle wasting.

[1]  G. Marchesini,et al.  Myofibrillar protein catabolic rates in cirrhotic patients with and without muscle wasting. , 1982, Clinical science.

[2]  F. Fiaccadori,et al.  Negative nitrogen balance in cirrhotics , 1981, La Ricerca in Clinica e in Laboratorio.

[3]  G. Marchesini,et al.  Muscle protein breakdown in liver cirrhosis and the role of altered carbohydrate metabolism , 1981, Hepatology.

[4]  M. Irving,et al.  N tau-Methylhistidine excretion and myofibrillar protein breakdown in patients receiving intravenous or enteral nutrition. , 1980, Clinical science.

[5]  M. Sugiura,et al.  Effect of spontaneous portal-systemic shunting on plasma insulin and amino acid concentrations. , 1980, Gastroenterology.

[6]  M. Elia,et al.  The 3-methylhistidine content of human tissues , 1979, British Journal of Nutrition.

[7]  E. Marliss,et al.  The short-term effects of protein intake on 3-methylhistidine excretion. , 1979, The American journal of clinical nutrition.

[8]  P. Royston,et al.  3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease. , 1979, Journal of neurology, neurosurgery, and psychiatry.

[9]  L. Ward,et al.  The excretion of 3-methylhistidine by the normal healthy adult. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[10]  A. Goldberg,et al.  Regulation and significance of amino acid metabolism in skeletal muscle. , 1978, Federation proceedings.

[11]  R. Uauy,et al.  Muscle protein breakdown rates in humans based on Nτ-methylhistidine (3-methylhistidine) content of mixed proteins in skeletal muscle and urinary output of Nτ-methylhistidine☆ , 1978 .

[12]  J. James,et al.  Influences of exogenous intake and nitrogen balance on plasma and brain aromatic amino acid concentrations. , 1978, Metabolism: clinical and experimental.

[13]  A. Livingstone,et al.  Tryptophan and hepatic coma. , 1978, Gastroenterology.

[14]  D. Williamson,et al.  Muscle-protein catabolism after injury in man, as measured by urinary excretion of 3-methylhistidine. , 1977, Clinical science and molecular medicine.

[15]  J. Fischer,et al.  Plasma amino acid patterns in hepatic encephalopathy of differing etiology. , 1977, Gastroenterology.

[16]  A. M. Ebeid,et al.  The effect of normalization of plasma amino acids on hepatic encephalopathy in man. , 1976, Surgery.

[17]  J. Fischer,et al.  ALTERATIONS IN BRAIN OCTOPAMINE AND BRAIN TYROSINE FOLLOWING PORTACAVAL ANASTOMOSIS IN RATS , 1976, Journal of neurochemistry.

[18]  J. Fischer,et al.  Brain tryptophan, plasma free tryptophan and distribution of plasma neutral amino acids. , 1976, Metabolism: clinical and experimental.

[19]  J. Fischer,et al.  The role of plasma amino acids in hepatic encephalopathy. , 1975, Surgery.

[20]  J. Kinney,et al.  Metabolism of 3-methylhistidine in man. , 1975, Metabolism: clinical and experimental.

[21]  M. R. Ball,et al.  Nitrogen sparing by carbohydrate in man: Intermittent or continuous enteral compared with continuous parenteral glucose. , 1975, Surgery.

[22]  A. Goldberg,et al.  Effects of insulin, glucose, and amino acids on protein turnover in rat diaphragm. , 1975, The Journal of biological chemistry.

[23]  A. Goldberg,et al.  Origin and possible significance of alanine production by skeletal muscle. , 1974, The Journal of biological chemistry.

[24]  A. Goldberg,et al.  Oxidation of amino acids by diaphragms from fed and fasted rats. , 1972, The American journal of physiology.

[25]  H. Munro,et al.  Metabolism of administered 3-methylhistidine. Lack of muscle transfer ribonucleic acid charging and quantitative excretion as 3-methylhistidine and its N-acetyl derivative. , 1972, The Journal of biological chemistry.

[26]  P. Felig,et al.  Alanine: Key Role in Gluconeogenesis , 1970, Science.

[27]  H. M. Whyte,et al.  The measurement of creatinine in plasma and urine. , 1958, The Australian journal of experimental biology and medical science.

[28]  P. Wright,et al.  The effect of branched-chain amino acids on body protein breakdown and synthesis in patients with chronic liver disease , 1983 .

[29]  岩崎 泰彦 Effect of spontaneous portal-systemic shunting on plasma insulin and amino acid concentrations , 1981 .

[30]  J. Fischer,et al.  Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. , 1974, American journal of surgery.